News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Chugai Pharmaceutical Ends Trading Day Up 5.9% on Favorable Obesity Drug Data
Chugai Pharmaceutical (4519.JP) closed the trading day at JPY8,844 today (20th), up 5.9% for the day.The company has granted Eli Lilly (LLY.US) the global development and commercia...
Reset
Send
The window will close in 5 seconds
Chugai Pharmaceutical Ends Trading Day Up 5.9% on Favorable Obesity Drug Data
Close
Recommend
2
Positive
1
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Chugai Pharmaceutical (4519.JP) closed the trading day at JPY8,844 today (20th), up 5.9% for the day.

The company has granted Eli Lilly (LLY.US)      the global development and commercialization rights for its obesity drug Orforglipron, which has also received approval for sale from the US Food and Drug Administration.

Last Thursday (16th), Eli Lilly announced the Phase-3 clinical trial results for Orforglipron, showing that it was non-inferior to insulin glargine in terms of risk of major adverse cardiovascular events and met its primary endpoint. The news added positive visibility to the prospects of the licensed asset.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.